Log In
Print this Print this

Avian flu (H5N1) Oral Vaccine (ND1.1)

Also known as: ND1

  Manage Alerts
Collapse Summary General Information
Company Vaxart Inc.
DescriptionOral formulation of a vaccine consisting of a vehicle engineered to express avian flu hemagglutinin (HA) and a toll-like receptor 3 (TLR3) ligand as a vaccine adjuvant
Molecular Target Influenza A virus hemagglutinin
Mechanism of Action 
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationInfluenza virus
Indication DetailsVaccinate against influenza (H5N1) virus
Regulatory Designation


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today